Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2017 April;83(4) > Minerva Anestesiologica 2017 April;83(4):392-401



Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


REVIEW   Freefree

Minerva Anestesiologica 2017 April;83(4):392-401

DOI: 10.23736/S0375-9393.16.11545-7


lingua: Inglese

Clinical indices and biomarkers for perioperative cardiac risk stratification: an update

Radmilo J., JANKOVIĆ 1, 2, Danica Z. MARKOVIĆ 2, Dušan T. SOKOLOVIĆ 3, Ivana ZDRAVKOVIĆ 4, Massimiliano SORBELLO 5

1 Department of Anesthesiology and Intensive Care, School of Medicine, University of Niš, Niš, Serbia; 2 Center for Anesthesiology and Reanimatology, Clinical Center of Niš, Niš, Serbia; 3 Department of Biochemistry, School of Medicine, University in Niš, Niš, Serbia; 4 Department of Anesthesiology and Reanimatology, Clinical Hospital Center ”Zvezdara“, Belgrade, Serbia; 5 Department of Anesthesia and Intensive Care, Vittorio Emanuele Policlinic, Catania, Italy


European Society of Cardiology (ESC)/ European Society of Anesthesiology (ESA) highlighted that anesthesiologist has a leading role in perioperative cardiovascular assessment and management in the year of 2014. During cardiovascular assessment one can rely on cooperation of multidisciplinary specialists like: other anesthesiologists, cardiologists and surgeons. For the purpose of precise systematization and decision making the Lee Score or NSQUIP database can be used besides the traditionally used ASA Score. Additional help is provided with specific palette of cardiac biomarkers like: cardiac troponins T, cardiac troponins I, C-reactive protein, N-terminal pro-brain natriuretic peptide, brain natriuretic peptide, etc. Biomarkers are considered to represent a foundation of evidence based medicine and they help anesthesiologists in the decision-making process. They increase the chance to achieve the best clinical outcome for each patient. An ideal biomarker does not exist and therefore new research are currently being conducted with the aim to find and declare more specific biomarkers like heart-type fatty acid-binding protein, micro RNA, PAMP and high sensitivity troponins T.

KEY WORDS: Biomarkers - MicroRNAs - Mid-regional pro-adrenomedullin, human - FABP3 protein, human

inizio pagina